Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016

This cohort study compares time trends in the use of neoadjuvant chemotherapy and survival rates among women with advanced-stage epithelial ovarian cancer.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA network open 2020-09, Vol.3 (9), p.e2017517-e2017517
Hauptverfasser:	Knisely, Anne T, St Clair, Caryn M, Hou, June Y, Collado, Fady Khoury, Hershman, Dawn L, Wright, Jason D, Melamed, Alexander
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma, Mucinous - pathology Adenocarcinoma, Mucinous - therapy Aged Antineoplastic Agents - therapeutic use Carcinoma, Endometrioid - pathology Carcinoma, Endometrioid - therapy Carcinoma, Ovarian Epithelial - pathology Carcinoma, Ovarian Epithelial - therapy Chemotherapy, Adjuvant - trends Cohort Studies Cytoreduction Surgical Procedures - trends Female Humans Middle Aged Neoadjuvant Therapy - trends Neoplasm Staging Neoplasms, Cystic, Mucinous, and Serous - pathology Neoplasms, Cystic, Mucinous, and Serous - therapy Oncology Online Only Ovarian cancer Ovarian Neoplasms - pathology Ovarian Neoplasms - therapy Progression-Free Survival Research Letter Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This cohort study compares time trends in the use of neoadjuvant chemotherapy and survival rates among women with advanced-stage epithelial ovarian cancer.
ISSN:	2574-3805 2574-3805
DOI:	10.1001/jamanetworkopen.2020.17517